{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T07:54:05Z","timestamp":1785311645054,"version":"3.55.0"},"reference-count":17,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100003196","name":"Ministero della Salute","doi-asserted-by":"publisher","award":["RF-2021-12372278"],"award-info":[{"award-number":["RF-2021-12372278"]}],"id":[{"id":"10.13039\/501100003196","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Magnetic Resonance Imaging Clinics of North America"],"published-print":{"date-parts":[[2023,11]]},"DOI":"10.1016\/j.mric.2023.06.006","type":"journal-article","created":{"date-parts":[[2023,8,2]],"date-time":"2023-08-02T21:22:08Z","timestamp":1691011328000},"page":"605-611","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Systematic Review and Metanalysis on the Role of Prostate-Specific Membrane Antigen Positron Emission Tomography\/Magnetic Resonance Imaging for Intraprostatic Tumour Assessment"],"prefix":"10.1016","volume":"31","author":[{"given":"Paola","family":"Mapelli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuele","family":"Ghezzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Spataro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolina","family":"Bezzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana Maria","family":"Samanes Gajate","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arturo","family":"Chiti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Picchio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.mric.2023.06.006_bib1","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.euros.2021.09.006","article-title":"Comparison of 68Ga-labeled prostate-specific membrane antigen ligand positron emission tomography\/magnetic resonance imaging and positron emission tomography\/computed tomography for primary staging of prostate cancer: a systematic review and meta-analysis","volume":"33","author":"Ling","year":"2021","journal-title":"Eur Urol Open Sci"},{"key":"10.1016\/j.mric.2023.06.006_bib2","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1038\/nrurol.2015.191","article-title":"Initial prostate cancer diagnosis and disease staging\u2014the role of choline-PET\u2013CT","volume":"12","author":"Mapelli","year":"2015","journal-title":"Nat Rev Urol"},{"key":"10.1016\/j.mric.2023.06.006_bib3","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1007\/s00345-018-2182-1","article-title":"68Ga-prostate specific membrane antigen (PSMA) positron emission tomography (PET) for primary staging of high-risk prostate cancer: a systematic review","volume":"36","author":"Corfield","year":"2018","journal-title":"World J Urol"},{"key":"10.1016\/j.mric.2023.06.006_bib4","doi-asserted-by":"crossref","first-page":"599","DOI":"10.2214\/AJR.20.23912","article-title":"Diagnostic accuracy of 68 Ga-PSMA PET\/CT for initial detection in patients with suspected prostate cancer: a systematic review and meta-analysis","volume":"216","author":"Satapathy","year":"2021","journal-title":"Am J Roentgenol"},{"key":"10.1016\/j.mric.2023.06.006_bib5","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1016\/j.euf.2016.11.002","article-title":"68Ga-labeled prostate-specific membrane antigen ligand positron emission tomography\/computed tomography for prostate cancer: a systematic review and meta-analysis","volume":"4","author":"von Eyben","year":"2018","journal-title":"Eur Urol Focus"},{"key":"10.1016\/j.mric.2023.06.006_bib6","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1055\/a-0830-4453","article-title":"Whole-body [18F]-FDG-PET\/MRI for oncology: a consensus recommendation","volume":"58","author":"Umutlu","year":"2019","journal-title":"Nuklearmedizin"},{"key":"10.1016\/j.mric.2023.06.006_bib7","doi-asserted-by":"crossref","first-page":"2068","DOI":"10.3390\/diagnostics11112068","article-title":"Preliminary results of an ongoing prospective clinical trial on the use of 68Ga-PSMA and 68Ga-DOTA-RM2 PET\/MRI in staging of high-risk prostate cancer patients","volume":"11","author":"Mapelli","year":"2021","journal-title":"Diagnostics"},{"key":"10.1016\/j.mric.2023.06.006_bib8","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1186\/s12874-022-01788-2","article-title":"Meta-DiSc 2.0: a web application for meta-analysis of diagnostic test accuracy data","volume":"22","author":"Plana","year":"2022","journal-title":"BMC Med Res Methodol"},{"key":"10.1016\/j.mric.2023.06.006_bib9","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1148\/radiol.2018180788","article-title":"Diagnostic accuracy of 68 Ga-PSMA-11 PET\/MRI compared with multiparametric MRI in the detection of prostate cancer","volume":"289","author":"Hicks","year":"2018","journal-title":"Radiology"},{"key":"10.1016\/j.mric.2023.06.006_bib10","doi-asserted-by":"crossref","first-page":"3702","DOI":"10.1007\/s00259-021-05355-7","article-title":"Detection of clinically significant prostate cancer with 18F-DCFPyL PET\/multiparametric MR","volume":"48","author":"Metser","year":"2021","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.mric.2023.06.006_bib11","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1007\/s00259-021-05604-9","article-title":"Prospective analysis of clinically significant prostate cancer detection with [18F]DCFPyL PET\/MRI compared to multiparametric MRI: a comparison with the histopathology in the radical prostatectomy specimen, the ProStaPET study","volume":"49","author":"Bodar","year":"2022","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.mric.2023.06.006_bib12","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.prnil.2022.03.003","article-title":"Diagnostic value of integrated 18F-PSMA-1007 PET\/MRI compared with that of biparametric MRI for the detection of prostate cancer","volume":"10","author":"Zeng","year":"2022","journal-title":"Prostate Int"},{"key":"10.1016\/j.mric.2023.06.006_bib13","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1148\/radiol.2021204093","article-title":"Diagnostic performance of 68 Ga prostate-specific membrane antigen PET\/MRI compared with multiparametric MRI for detecting clinically significant prostate cancer","volume":"301","author":"Margel","year":"2021","journal-title":"Radiology"},{"key":"10.1016\/j.mric.2023.06.006_bib14","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/j.eururo.2015.12.053","article-title":"Simultaneous 68Ga-PSMA HBED-CC PET\/MRI improves the localization of primary prostate cancer","volume":"70","author":"Eiber","year":"2016","journal-title":"Eur Urol"},{"key":"10.1016\/j.mric.2023.06.006_bib15","doi-asserted-by":"crossref","first-page":"3315","DOI":"10.1007\/s00259-021-05261-y","article-title":"Diagnostic performance of 68Ga-PSMA-11 PET\/MRI-guided biopsy in patients with suspected prostate cancer: a prospective single-center study","volume":"48","author":"Ferraro","year":"2021","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.mric.2023.06.006_bib16","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/s41824-022-00135-4","article-title":"68Ga-PSMA-11 PET\/MRI versus multiparametric MRI in men referred for prostate biopsy: primary tumour localization and interreader agreement","volume":"6","author":"Ferraro","year":"2022","journal-title":"Eur J Hybrid Imaging"},{"key":"10.1016\/j.mric.2023.06.006_bib17","doi-asserted-by":"crossref","first-page":"1822","DOI":"10.2967\/jnumed.122.263897","article-title":"68 Ga-PSMA-11 PET\/MRI in patients with newly diagnosed intermediate- or high-risk prostate adenocarcinoma: PET findings correlate with outcomes after definitive treatment","volume":"63","author":"Moradi","year":"2022","journal-title":"J\u00a0Nucl Med"}],"container-title":["Magnetic Resonance Imaging Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1064968923000545?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1064968923000545?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T04:47:18Z","timestamp":1761022038000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1064968923000545"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11]]},"references-count":17,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023,11]]}},"alternative-id":["S1064968923000545"],"URL":"https:\/\/doi.org\/10.1016\/j.mric.2023.06.006","relation":{},"ISSN":["1064-9689"],"issn-type":[{"value":"1064-9689","type":"print"}],"subject":[],"published":{"date-parts":[[2023,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Systematic Review and Metanalysis on the Role of Prostate-Specific Membrane Antigen Positron Emission Tomography\/Magnetic Resonance Imaging for Intraprostatic Tumour Assessment","name":"articletitle","label":"Article Title"},{"value":"Magnetic Resonance Imaging Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mric.2023.06.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}